NanoVector licenses biologic nanoparticle drug-delivery technology

12/4/2008 | Nanotechnology Now

NanoVector has licensed a plant-virus nanoparticle drug-delivery system designed for the selective targeting of tumors and the intracellular delivery of anti-cancer drugs. The system, which was developed by researchers at North Carolina State University, could help improve the efficacy of cytotoxic drugs and reduce their adverse side effects.

View Full Article in:

Nanotechnology Now

Published in Brief:

SmartBrief Job Listings for Health Care

Job Title Company Location
MGR POST MARKET STUDIES - 14000001LK
Abbott
Santa Ana, CA
Regulatory Analyst
Delta Dental
Alpharetta, GA
Eastern Zone Sales Director
Regenesis Biomedical
Multiple Locations, SL_Multiple Locations
Senior Financial Analyst - Growing Manager Care Health Org
Fallon Community Health Plan
Worcester, MA
Associate Director, Regulatory Affairs - Promotional Review
Novo Nordisk
Princeton, NJ